Development of an inhalable antiviral powder formulation against respiratory syncytial virus.
Heida R, Akkerman R, Jacob Silva PH, Lakerveld AJ, Ortiz D, Bigogno C, Gasbarri M, van Kasteren PB, Stellacci F, Frijlink HW, Huckriede ALW, Hinrichs WLJ.
Heida R, et al. Among authors: huckriede alw.
J Control Release. 2023 May;357:264-273. doi: 10.1016/j.jconrel.2023.03.059. Epub 2023 Apr 5.
J Control Release. 2023.
PMID: 37015293
Free article.